Download PDF
J Neurol Surg B Skull Base 2022; 83(S 02): e545-e554
DOI: 10.1055/s-0041-1735559
Original Article

Comparison of Outcomes following Primary and Repeat Resection of Craniopharyngioma

Alexander A. Aabedi 
1   School of Medicine, University of California San Francisco, San Francisco, California, United States
,
Jacob S. Young
2   Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States
,
Ryan R. L. Phelps
1   School of Medicine, University of California San Francisco, San Francisco, California, United States
,
Ethan A. Winkler
2   Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States
,
Michael W. McDermott
3   Baptist Hospital, Florida International University, Miami, Florida, United States
,
Philip V. Theodosopoulos
2   Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Introduction The management of recurrent craniopharyngioma is complex with limited data to guide decision-making. Some reports suggest reoperation should be avoided due to an increased complication profile, while others have demonstrated that safe reoperation can be performed. For other types of skull base lesions, maximal safe resection followed by adjuvant therapy has replaced radical gross total resection due to the favorable morbidity profiles.

Methods Seventy-one patients underwent resection over a 9-year period for craniopharyngioma and were retrospectively reviewed. Patients were separated into primary resection and reoperation cohorts and stratified by surgical approach (endonasal vs. cranial) and survival analyses were performed based on cohort and surgical approach.

Results Fifty patients underwent primary resection, while 21 underwent reoperation for recurrence. Fifty endonasal transsphenoidal surgeries and 21 craniotomies were performed. Surgical approaches were similarly distributed across cohorts. Subtotal resection was achieved in 83% of all cases. There were no differences in extent of resection, visual outcomes, subsequent neuroendocrine function, and complications across cohorts and surgical approaches. The median time to recurrence was 87 months overall, and there were no differences by cohort and approach. The 5-year survival rate was 81.1% after reoperation versus 93.2% after primary resection.

Conclusion Compared with primary resection, reoperation for craniopharyngioma recurrence is associated with similar functional and survival outcomes in light of individualized surgical approaches. Maximal safe resection followed by adjuvant radiotherapy for residual tumor likely preserves vision and endocrine function without sacrificing overall patient survival.

Keywords

craniopharyngioma - reoperation - endonasal - transcranial - maximal safe resection


Publication History

Received: 06 May 2021

Accepted: 25 July 2021

Article published online:
10 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ghirardello S, Hopper N, Albanese A, Maghnie M. Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders. J Pediatr Endocrinol Metab 2006; 19 (Suppl. 01) 413-421
    PubMedGoogle Scholar
  • 2 Thompson CJ, Costello RW, Crowley RK. Management of hypothalamic disease in patients with craniopharyngioma. Clin Endocrinol (Oxf) 2019; 90 (04) 506-516
    CrossrefPubMedGoogle Scholar
  • 3 Zoicas F, Schöfl C. Craniopharyngioma in adults. Front Endocrinol (Lausanne) 2012; 3: 46
    CrossrefPubMedGoogle Scholar
  • 4 Conger AR, Lucas J, Zada G, Schwartz TH, Cohen-Gadol AA. Endoscopic extended transsphenoidal resection of craniopharyngiomas: nuances of neurosurgical technique. Neurosurg Focus 2014; 37 (04) E10
    CrossrefPubMedGoogle Scholar
  • 5 Liu JK, Christiano LD, Gupta G, Carmel PW. Surgical nuances for removal of retrochiasmatic craniopharyngiomas via the transbasal subfrontal translamina terminalis approach. Neurosurg Focus 2010; 28 (04) E6
    CrossrefPubMedGoogle Scholar
  • 6 Nanda A, Narayan V, Mohammed N, Savardekar AR, Patra DP. Microsurgical resection of suprasellar craniopharyngioma-technical purview. J Neurol Surg B Skull Base 2018; 79 (Suppl. 03) S247-S248
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Varlotto J, DiMaio C, Grassberger C. et al. Multi-modality management of craniopharyngioma: a review of various treatments and their outcomes. Neurooncol Pract 2016; 3 (03) 173-187
    PubMedGoogle Scholar
  • 8 Breshears JD, Liu SJ, Vasudevan H. et al. Multiplatform molecular profiling of vestibular schwannoma reveals 2 subgroups of tumors with distinct radiographic features and a methylation-based predictor of local recurrence. Neurosurgery 2019; 66 (Suppl. 01) 604
    PubMedGoogle Scholar
  • 9 Maira G, Anile C, Albanese A, Cabezas D, Pardi F, Vignati A. The role of transsphenoidal surgery in the treatment of craniopharyngiomas. J Neurosurg 2004; 100 (03) 445-451
    CrossrefPubMedGoogle Scholar
  • 10 Yang I, Sughrue ME, Rutkowski MJ. et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 2010; 28 (04) E5
    CrossrefPubMedGoogle Scholar
  • 11 Barua KK, Ehara K, Kohmura E, Tamaki N. Treatment of recurrent craniopharyngiomas. Kobe J Med Sci 2003; 49 (5-6): 123-132
    PubMedGoogle Scholar
  • 12 Gautier A, Godbout A, Grosheny C. et al; Craniopharyngioma Study Group. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab 2012; 97 (04) 1258-1267
    CrossrefPubMedGoogle Scholar
  • 13 Gupta DK, Ojha BK, Sarkar C, Mahapatra AK, Mehta VS. Recurrence in craniopharyngiomas: analysis of clinical and histological features. J Clin Neurosci 2006; 13 (04) 438-442
    CrossrefPubMedGoogle Scholar
  • 14 Rajan B, Ashley S, Gorman C. et al. Craniopharyngioma–a long-term results following limited surgery and radiotherapy. Radiother Oncol 1993; 26 (01) 1-10
    CrossrefPubMedGoogle Scholar
  • 15 Wisoff JH. Surgical management of recurrent craniopharyngiomas. Pediatr Neurosurg 1994; 21 (Suppl. 01) 108-113
    CrossrefPubMedGoogle Scholar
  • 16 Bao Y, Pan J, Qi ST, Lu YT, Peng JX. Origin of craniopharyngiomas: implications for growth pattern, clinical characteristics, and outcomes of tumor recurrence. J Neurosurg 2016; 125 (01) 24-32
    CrossrefPubMedGoogle Scholar
  • 17 Dhandapani S, Singh H, Negm HM. et al. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas. J Neurosurg 2017; 126 (02) 418-430
    CrossrefPubMedGoogle Scholar
  • 18 Prieto R, Castro-Dufourny I, Carrasco R, Barrios L, Pascual JM. Craniopharyngioma recurrence: the impact of tumor topography. J Neurosurg 2016; 125 (04) 1043-1049
    CrossrefPubMedGoogle Scholar
  • 19 Wisoff JH, Boyett JM, Berger MS. et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group Trial No. CCG-945. Neurosurg Focus 1998; 4 (05) E2
    CrossrefPubMedGoogle Scholar
  • 20 Chiou SM, Lunsford LD, Niranjan A, Kondziolka D, Flickinger JC. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro-oncol 2001; 3 (03) 159-166
    CrossrefPubMedGoogle Scholar
  • 21 Minniti G, Esposito V, Amichetti M, Enrici RM. The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev 2009; 32 (02) 125-132 , discussion 132
    CrossrefPubMedGoogle Scholar
  • 22 Jeswani S, Nuño M, Wu A. et al. Comparative analysis of outcomes following craniotomy and expanded endoscopic endonasal transsphenoidal resection of craniopharyngioma and related tumors: a single-institution study. J Neurosurg 2016; 124 (03) 627-638
    CrossrefPubMedGoogle Scholar
  • 23 Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Tyler-Kabara EC, Wang EW, Snyderman CH. Endoscopic endonasal surgery for craniopharyngiomas: surgical outcome in 64 patients. J Neurosurg 2013; 119 (05) 1194-1207
    CrossrefPubMedGoogle Scholar
  • 24 Madsen PJ, Buch VP, Douglas JE. et al. Endoscopic endonasal resection versus open surgery for pediatric craniopharyngioma: comparison of outcomes and complications. J Neurosurg Pediatr 2019; 24 (03) 1-10
    CrossrefPubMedGoogle Scholar
  • 25 Akutsu H. Selection of surgical approach for craniopharyngiomas: endoscopic endonasal surgery or transcranial surgery. Japanese Journal of Neurosurgery 2018; 27 (06) 456-462
    CrossrefPubMedGoogle Scholar
  • 26 Nesvick CL, Thompson CJ, Boop FA, Klimo Jr P. Case-control studies in neurosurgery. J Neurosurg 2014; 121 (02) 285-296
    CrossrefPubMedGoogle Scholar
  • 27 Kassam AB, Thomas A, Carrau RL. et al. Endoscopic reconstruction of the cranial base using a pedicled nasoseptal flap. Neurosurgery 2008; 63 (1, suppl 1): discussion ONS52–ONS53 ONS44-ONS52
    PubMedGoogle Scholar
  • 28 Qiao N. Endocrine outcomes of endoscopic versus transcranial resection of craniopharyngiomas: a system review and meta-analysis. Clin Neurol Neurosurg 2018; 169: 107-115
    CrossrefPubMedGoogle Scholar
  • 29 Yaşargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 1990; 73 (01) 3-11
    CrossrefPubMedGoogle Scholar
  • 30 Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital. Childs Nerv Syst 2005; 21 (8-9): 729-746
    CrossrefPubMedGoogle Scholar
  • 31 Wen BC, Hussey DH, Staples J. et al. A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. Int J Radiat Oncol Biol Phys 1989; 16 (01) 17-24
    CrossrefPubMedGoogle Scholar
  • 32 Liubinas SV, Munshey AS, Kaye AH. Management of recurrent craniopharyngioma. J Clin Neurosci 2011; 18 (04) 451-457
    CrossrefPubMedGoogle Scholar
  • 33 Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera J-P, Puget S. Craniopharyngioma. Nat Rev Dis Primers 2019; 5 (01) 75
    CrossrefPubMedGoogle Scholar
  • 34 Elliott RE, Hsieh K, Hochm T, Belitskaya-Levy I, Wisoff J, Wisoff JH. Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children. J Neurosurg Pediatr 2010; 5 (01) 30-48
    CrossrefPubMedGoogle Scholar
  • 35 Lo AC, Howard AF, Nichol A. et al. Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Int J Radiat Oncol Biol Phys 2014; 88 (05) 1011-1018
    CrossrefPubMedGoogle Scholar
  • 36 O'steen L, Indelicato DJ. Advances in the management of craniopharyngioma. F1000 Res 2018; 7: 1632
    CrossrefPubMedGoogle Scholar
  • 37 Schoenfeld A, Pekmezci M, Barnes MJ. et al. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol 2012; 108 (01) 133-139
    CrossrefPubMedGoogle Scholar
  • 38 Akinduro OO, Izzo A, Lu VM. et al. Endocrine and visual outcomes following gross total resection and subtotal resection of adult craniopharyngioma: systematic review and meta-analysis. World Neurosurg 2019; 127: e656-e668
    CrossrefPubMedGoogle Scholar
  • 39 Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 2010; 76 (3, suppl) S28-S35
    CrossrefPubMedGoogle Scholar
  • 40 Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol 2017; 13 (01) 52-64
    CrossrefPubMedGoogle Scholar
  • 41 Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 2005; 23 (10) 2256-2263
    CrossrefPubMedGoogle Scholar